Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Subcutaneous Interferon β-1a May Protect against Cognitive Impairment in Patients with Relapsing-Remitting Multiple Sclerosis: 5-Year Follow-up of the COGIMUS Study.
Risk of multiple sclerosis after optic neuritis in patients with normal baseline brain MRI.
Layered genetic control of DNA methylation and gene expression: a locus of multiple sclerosis in healthy individuals.
Anodal transcranial direct current stimulation of motor cortex does not ameliorate spasticity in multiple sclerosis.
Meningeal Tertiary Lymphoid Tissues and Multiple Sclerosis: A Gathering Place for Diverse Types of Immune Cells during CNS Autoimmunity.
Targeting the endocannabinoid system with cannabinoid receptor agonists: pharmacological strategies and therapeutic possibilities.
Multiple sclerosis: Evidence for B-cell exchange across the blood-brain barrier.
Partnering to Increase Access to Community Exercise Programs for People With Stroke, Acquired Brain Injury and Multiple Sclerosis.
Multiple sclerosis: Blood-based biomarkers provide insight into progressive MS.
Altered thalamic functional connectivity in multiple sclerosis.
DOPAMINE AND T CELLS: Receptors, Direct and Potent Effects, Endogenous Production and Abnormalities in Autoimmune, Neurological and Psychiatric Diseases.
Effects of Bu Shen Yi Sui Capsule on Th17/Treg cytokines in C57BL/6 mice with experimental autoimmune encephalomyelitis.
Fingolimod first-dose effects in patients with relapsing multiple sclerosis concomitantly receiving selective serotonin-reuptake inhibitors.
A rare P2X7 variant Arg307Gln with absent pore formation function protects against neuroinflammation in multiple sclerosis.
Genome-wide analysis of wild-type Epstein-Barr virus genomes derived from healthy individuals of the 1000 Genomes Project.
Costs of formal and informal home care and quality of life for patients with multiple sclerosis in sweden.
Enhanced patient support services improve patient persistence with multiple sclerosis treatment.
Meningeal inflammation and demyelination in a patient clinically diagnosed with acute disseminated encephalomyelitis.
The impact of self-transcendence on physical health status promotion in multiple sclerosis patients attending peer support groups.
Transient global amnesia revealing multiple sclerosis.
Examining the factor structure of the multiple sclerosis impact scale.
New insights into an autoimmune mechanism, pharmacological treatment and relationship between multiple sclerosis and inflammatory bowel disease.
Regulatory and T Effector Cells Have Overlapping Low to High Ranges in TCR Affinities for Self during Demyelinating Disease.
Nogo Receptor Signaling Restricts Adult Neural Plasticity by Limiting Synaptic AMPA Receptor Delivery.
The Role of 3-O-Sulfogalactosylceramide, Sulfatide, in the Lateral Organization of Myelin Membrane.
Pages
« first
‹ previous
…
473
474
475
476
477
478
479
480
481
…
next ›
last »